Nuvation Bio (NYSE: NUVB) recently received a number of ratings updates from brokerages and research firms: 6/3/2024 – Nuvation Bio had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock. 5/24/2024 – Nuvation Bio had its “outperform” rating reaffirmed by analysts at Wedbush. They now […]